Mild Neurocognitive Disorder (MNCD) represents a subtle decline in cognitive abilities, beyond what is considered normal for one's age but not yet significantly impairing daily life. This condition is often linked with Alzheimer's disease and other types of dementia. People with MNCD may notice mild memory issues, occasional difficulty with language or decision-making, and other subtle cognitive challenges.
In the context of Alzheimer's disease, MNCD can serve as an early indicator, where initial symptoms such as forgetting recent events or struggling with familiar tasks begin to emerge. Seeking timely medical evaluation is crucial for those experiencing these symptoms, as early detection enables better management strategies and future planning. While MNCD doesn't always progress to full-blown dementia, proactive measures such as cognitive exercises and adopting a healthy lifestyle may help delay its advancement and enhance overall well-being.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States